MedShr Wins Prestigious King's Award for Enterprise for Innovation
We are incredibly proud and honoured to announce that MedShr has been recognised with the prestigious King's Award for Enterprise for Innovation!
We are incredibly proud and honoured to announce that MedShr has been recognised with the prestigious King's Award for Enterprise for Innovation!
Sickle cell disease (SCD) affects over 400,000 newborns annually, with particularly high mortality rates in low- and middle-income countries (LMICs) such as India and Sub-Saharan Africa (SSA). At this year's American Society of Hematology conference in San Diego, MedShr founder Dr Asif Qasim presents a groundbreaking mobile-first medical education programme and its impact on SCD diagnosis and management in Kenya, Ghana, Zambia, Uganda, Tanzania and India.
Representing a novel approach to HCP engagement and medical education, MedShr secured a Gold and a Silver Award for the “Engaging HCP Communities” category and a Silver for “Healthcare Charities, Patient Associations and the NHS”
June 2023
2 March, 2023
Breast cancer is the most common type of cancer in the UK. It requires multidisciplinary care, starting from primary care to surgery to cutting-edge medical oncology. In October, during Breast Cancer Awareness Month, we are discussing clinical cases, guidelines and the latest research to better improve patient care.
In this article, we take a look at breast cancer screening, treatment and late-breaking clinical trial results.
MedShr is excited to launch MedShr docsearch, an AI-driven platform that analyses published medical evidence and rapidly reviews complex scientific literature. This technology is being put in the hands of clinicians and academics for the first time, exclusively through MedShr.